Shandong Jincheng Pharmaceutical Group Co., Ltd. engages in the research and development, bio-pharmaceuticals, production and sale of III and IV cephalosporin intermediates. Its products are categorized into the following divisions: Characteristic Bulk Drugs, Pharmaceutical Intermediates, and Fine Chemicals. The company was founded by Hong Fu Zhao on January 12, 2004 and is headquartered in Zibo, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company